JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2016, Vol. 54 ›› Issue (1): 45-47.doi: 10.6040/j.issn.1671-7554.0.2015.343

Previous Articles     Next Articles

Relationship between abdominal distension and small intestine bacterial overgrowth in type 2 diabetic patients

ZHANG Li1, ZHU Huiming1, WANG Yanmei2, JIANG Di1, SUN Xianjiu1, LE Youlin2   

  1. 1. Department of Gastroenterology, Donghua Hospital of Dongguan, Dongguan 523000, Guangdong, China;
    2. Nursing College of Henan University, Kaifeng 475000, Henan, China
  • Received:2015-04-01 Online:2016-01-11 Published:2016-01-11

PDF (PC)

149

Abstract: Objective To explore the relationship between abdominal distension and small intestine bacterial overgrowth(SIBO)in type 2 diabetic patients. Methods A total of 96 type 2 diabetic patients were divided into 4 groups: normal blood glucose and no abdominal distention group(control group), normal blood glucose and abdominal distension group(abdominal distension group), hyperglycemia without abdominal distension group, and hyperglycemia and abdominal distention group. SIBO and the mouth-intestine transit time were detected with lactulose hydrogen breath test, and the results of the control group were compared with those of the other groups. Results The positive rate of SIBO in the hyperglycemia and abdominal distention group was higher than in the other groups, and the difference was significant. There was difference in the positive rate of SIBO between the control group and abdominal distension group(P<0.05). There were significant differences in the mouth-intestine transit time between the control group and the other 3 groups(P<0.01). Conclusion Type 2 diabetic patients with abdominal distention are more liable to have SIBO. The long mouth-intestine transit time may be related to abdominal distension.

Key words: Type 2 diabetes, Small intestinal bacterial overgrowth, Hydrogen breath test

CLC Number: 

  • R575
[1] 张波, 杨文英. 糖尿病防治在中国[J]. 中华糖尿病杂志, 2015, 7(1):3-5.
[2] Gabrielli M, D'Angelo G, Di Rienzo T, et al. Diagnosis of small intestinal bacterial overgrowth in the clinical practice[J]. Eur Rev Med Pharmacol Sci, 2013, 17(2):30-35.
[3] Jan Bures, Jiri Cyrany, Darina Kohoutova, et al. Small intestinal bacterial overgrowth syndrome[J]. World J Gastroenterol, 2010, 16(24):2978-2990.
[4] 王倩,张莹,侯为开,等.2型糖尿病性腹泻与肠神经系统病变关系的探讨[J].山东大学学报(医学版),2011, 49(8):13-20. WANG Qian, ZHANG Ying, HOU Weikai, et al. Correlation between type 2 diabetes associated diarrhea and changes of enteric nervous system[J]. Journal of Shandong University(Health Sciences), 2011, 49(8):13-20.
[5] Rana SV, Malik A. Hydrogen breath tests in gastrointestinal diseases[J]. Indian J Clin Biochem, 2014, 29(4):398-405.
[6] Di Stefano M, Mengoli C, Bergonzi M, et al. Hydrogen breath test and intestinal gas production[J]. Eur Rev Med Pharmacol Sci, 2013, 17(2):36-38.
[7] Rana SV, Sharma S, Kaur J, et al. Comparison of lactulose and glucose breath test for diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome[J]. Digestion, 2012, 85(3):243-247.
[8] Kwak DS, Jun DW, Seo JG, et al. Short-term probiotic therapy alleviates small intestinal bacterial overgrowth, but does not improve intestinal permeability in chronic liver disease[J]. Eur J Gastroenterol Hepatol, 2014, 26(12):1353-1359.
[9] Drossman DA. Treatment for bacterial overgrowth in the irritable bowel syndrome [J]. Ann Intern Med, 2006, 145(8):626-628.
[10] Hulston CJ, Churnside AA, Venables MC. Probiotic supplementation prevents high-fat, overfeeding-induced insulin resistance in human subjects[J]. Br J Nutr, 2015, 113(4):596-602.
[1] SU Ping, YANG Yachao, YANG Yang, JI Jiadong, DAYIMU Alimu, LI Min, XUE Fuzhong, LIU Yanxun. Prediction models on the onset risks of type 2 diabetes among the health management population [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(6): 82-86.
[2] LI Shuai, WANG Yalin, SUN Zhongwen, ZHU Meijia. Expression changes and mechanism of Nod-like receptor protein 3 inflammasome in the cerebral microvascular endothelial cells in type 2 diabetes mellitus [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(3): 6-11.
[3] YANG Yang, ZHANG Guang, ZHANG Chengqi, SONG Xinhong, XUE Fuzhong, WANG Ping, WANG Li, LIU Yanxun. A prediction model for type 2 diabetes risks: a cohort study based on health examination [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(9): 69-72.
[4] PENG Li, QIANG Ye, ZHAO Huichen, CHEN Shihong, YAO Weidong, LIU Yuantao. Clinical studies on type 2 diabetic patients treated with sitagliptin [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(8): 60-63.
[5] LIN Dong, GUAN Qingbo. Association of serum testosterone level and non-alcoholic fatty liver disease in male patients with T2DM [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(7): 33-37.
[6] Muhadasi TUERXUNYIMING, Patamu MOHEMAITI, Tuolanguli MAIMAITIKUERBAN. Association of CDKAL1 rs10946398 C/A polymorphism with type 2 diabetes [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(2): 75-85.
[7] YU Ning, GAO Yanyan, XIAN Yuxin, NIU Jiapeng, LI Li, WANG Jing, CAO Caixia. Effect of exenatide on serum chemerin level and liver fat contents in type 2 diabetes mellitus combined with non-alcoholic fatty liver disease patients [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(11): 51-55.
[8] LIU Yanxun, LIU Jia, ZHANG Tao, WANG Lu, XUE Fuzhong, WANG Ping. Type 2 diabetes mellitus associated with thyroid nodules: a longitudinal health check-up cohort study [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(8): 83-86.
[9] PEI Leilei, SUN Zhonghua, LI Zhe, ZHAO Wenping. Effects of sitagliptin combined with high-dose insulin on type 2 diabetes mellitus [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(2): 39-42.
[10] HU Fangzhi, ZHANG Zhengjun, GENG Houfa, LIANG Qiuhua, SUN Lin. Relationship between microalbuminuria and brain damage in patients with type 2 diabetes mellitus [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(2): 43-47.
[11] LI Fang. Association between receptor of advanced glycation end products gene polymorphisms, soluble receptor of advanced glycation end products and susceptibility of type 2 diabetes mellitus [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(12): 57-61.
[12] LI Hanbing, GAO Yanyan, LI Li, CAO Caixia, XIAN Yuxin, WANG Jing, NIU Jiapeng. Effect of lansoprazole and exenatide on gastrin and oxyntomodulin in patients with type 2 diabetes [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(11): 64-68.
[13] ZHANG Nan1, YUAN Zhongshang2, ZHANG Xu1, ZHANG Yikun1, YU Chunxiao1, GAO Ling3, ZHAO Jiajun1, GUAN Qingbo1, GUAN Liying4. Association between serum testosterone and lipid profile in men with type 2 diabetes mellitus [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(4): 58-61.
[14] LIU Li, SHAO Yuhan. Correlation analysis of type 2 diabetes with diabetes family history and hypertension [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(12): 64-68.
[15] TIAN Meng, WU Chuanlong, QI Lin, LIU Yan, WANG Chuan, ZHAO Ruxing, LIANG Kai, SONG Jun, HOU Xinguo, CHEN Li. Dynamics of fasting glucagon and fasting glucagon /insulin ratio with diabetes duration in patients with type 2 diabetes [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(11): 33-37.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd